WNY1613
Product Specifications
CAS Number
2650546-39-5
Target
Others|||PI3K|||Apoptosis
Related Pathways
PI3K/Akt/mTOR signaling|||Apoptosis|||Others
Bioactivity
WNY1613 is a potent and selective PI3K? inhibitor with a piperazinone-containing purine scaffold, exhibiting anti-NHL effects both in vitro and in vivo by inhibiting phosphorylation of downstream components of PI3K in NHL cell lines and inducing apoptosis in cancer cells.
Smiles
C(C)C=1N(C=2C(N1)=CC=CC2)C3=NC(=C4C(=N3)N(C)C(CN5C(=O)CN(C(=O)C6CCC6)CC5)=N4)N7CCOCC7
Molecular Formula
C29H35N9O3
Molecular Weight
557.65
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LS006289-20ug 20 µg
Serum amyloid A2 (SAA2) (NM_030754) Human Over-expression Lysate
Ask
View Details 
207439-01 5 µg
VEGF 164, Recombinant, Mouse, 164aa (Vegfa, Vascular Endothelial Growth Factor A, VEGF-A, Vascular Permeability Factor, VPF, Vegf)
Ask
View Details 207439-02 50 µg
VEGF 164, Recombinant, Mouse, 164aa (Vegfa, Vascular Endothelial Growth Factor A, VEGF-A, Vascular Permeability Factor, VPF, Vegf)
Ask
View Details MBS6190625-01 0.1 mL
HSFY1 (Heat Shock Transcription Factor, Y-linked, Heat Shock Transcription Factor 2-like Protein, HSF2-like, HSF2L, HSFY, HSFY2, HSF2L, HSFY) (MaxLight 405)
Ask
View Details